Power of Attorney for Kazia Therapeutics Ltd

This filing is an Exhibit 24, a Limited Power of Attorney, appointing John E. Friend II and Jeffrey Bonacorda as attorneys-in-fact for Sudha Rao, Chief Scientific Officer of Kazia Therapeutics Limited. The attorneys are authorized to execute and file various SEC forms, including Form 3, 4, 5, Schedule 13D, and 13G, on behalf of Ms. Rao. They can perform all necessary acts for the completion and timely filing of these forms and any amendments. The Power of Attorney remains in effect until Ms. Rao is no longer required to file such forms or until earlier revoked. It supersedes any prior powers of attorney and will expire if an attorney-in-fact ceases to be an employee or affiliate of the Company. Ms. Rao acknowledges that the attorneys and the Company are not assuming her filing responsibilities and agrees to indemnify them against any false or misleading information provided.